Clinical Trials Logo

Clinical Trial Summary

The bipolar depression patients of 18-55 years old were recruited. At the time of enrollment, the demographic, symptomatic, neuropsychological, neurobiological and genetic data was collected. After the completion of the baseline assessment and examination, the patients were given lithium carbonate or lithium carbonate combined with SSRI antidepressant treatment. Clinical evaluation was performed at 2 and 8 weeks after treatment, including the therapeutic efficacy and adverse drug reactions, and monitoring of serum lithium concentration. The patients further receive the fMRI scans after treatment for 8 weeks. Through above work, this study aimed to provide some guidance for the use of antidepressants in patients with bipolar depression.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Bipolar Disorder
  • the Use of Antidepressants in Patients With Bipolar Depression

NCT number NCT03148535
Study type Interventional
Source Peking University
Contact Ji-Tao Li, MD
Phone 010-62723742
Email ljt_102124@163.com
Status Recruiting
Phase Phase 4
Start date June 1, 2017
Completion date December 1, 2018